News

THYLACINE

Thylacine Biotherapeutics Licenses Novel Antiviral Peptide Platform from Columbia University

Irving Institute for Clinical and Translational Research

Narratives of Discovery

Leica Microsystems and ASI announce partnership to commercialize customizable microscope for advanced users

The advanced system was unveiled for the first time at Cell Bio 2022 and uniquely combines gentle imaging, conventional sample preparation and high-speed volumetric imaging to capture fast dynamics in three dimensions. The system is based on SCAPE technology developed by Columbia's Dr. Elizabeth Hillman.

BIOCENTURY

Getting start-ups started faster

WALL STREET JOURNAL

A New Shot at Using Fish Oil

ALEXANDRIA LAUNCHLABS

Alexandria Real Estate Equities, Inc. Celebrates the Grand Opening of Alexandria LaunchLabs at Columbia to Accelerate the Commercialization of Novel Translational Science to Meet Significant Unmet Medical Needs

U.S. Secretary of Commerce Gina Raimondo Appoints U.S. Patent and Trademark Office Director Kathi Vidal to Serve as Third Federal Co-Chair of National Advisory Council on Innovation & Entrepreneurship (NACIE)

VALO HEALTH

Valo Health Acquires TARA Biosystems Creating First of its Kind Vertically Integrated Cardiovascular Platform

TERRAN BIOSCIENCES

Terran Biosciences announces licensing deal with Columbia University for exclusive worldwide rights to proprietary CNS biomarker software platform

PROJENX

ProJenX launches to advance novel, targeted therapies for ALS and other brain diseases

BLACKROCK NEUROTECH

High Performing Algorithm to Translate Paralyzed Patients' Thoughts into Real-time Prosthetic Movements

TECH TRANSFER TACTICS

Columbia program takes in non-university ventures to boost impact, grow ecosystem